Events

Views Navigation

Event Views Navigation

Today

  • The Connection Between Mental Health and Opioid Use Disorder

    Presenter: Mark Duncan, MD, Assistant Professor, University of Washington, Director, UW Psychiatry and Addictions Case Conference Sponsor: American Psychiatric Association (APA) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, social workers, pharmacists, and healthcare teams Credit Designations Available: AAPA Category 1 CME, Social Work CE Credit, Nursing Contact Hours, Pharmacy CE […]

  • Comparing Methods of Buprenorphine Treatment Initiation in Patients Using Fentanyl

    Presenter: Adam Bisaga, MD Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. This talk discusses substance use disorder treatment in a post-COVID world. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the […]

  • Illicit Drug Supply: Fentanyl and Xylazine

    Presenter: Richard Dawson, PhD, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry This presentation will explore current […]

  • Substance Use Disorders in Late Life

    Register Now   Presenters: Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, […]

  • Nurses’ Practices with People Experiencing Opioid Use Disorder

    Register Now   Presenter: Timothy J. Sowicz, PhD, RN Cost: No Fee Target audience: This activity is designed for for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators. This […]

  • Treatment Considerations in the Age of Fentanyl

    Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl […]

  • Initiating Buprenorphine for Patients Using Fentanyl

    Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations […]

  • Xylazine and How it Harms People Who Use Drugs

    Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review […]

  • Opioid Use Disorder and Social Determinants of Health

    Presenters:   Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social […]

  • Drug Use in Pregnancy (ASAM FAME Session 7)

    Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, […]

  • A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior

    This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for substance use disorder, including in rural areas. Register and attend to learn more! Speaker: Barbara "Basia" Andraka-Christou, PhD, JD, Assistant Professor in the School of […]

  • Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective

    Presenters: Mark Parrino, President and CEO of The American Association for the Treatment of Opioid Dependence, Inc. Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health Sponsor: National Council for Mental Wellbeing--NCMW Credit designational available: None Target Audience: Interprofessional teams, patients, educators, nurses, physicians, psychiatrists, psychologists, executives, clinical staff, administrators and social […]

  • Buprenorphine in the Age of Fentanyl: Discussing the New Guidance

    Presenter: John Mariani, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

  • Reaching People Where They’re At: Smoking Cessation Treatment Delivery at Your Door

    This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling, each demonstrating feasibility and efficacy of a simple yet novel treatment approach to reach a broad spectrum of smokers, including those who may not yet want […]

  • Buprenorphine Dosing and Preparations in the Era of Fentanyl

    Presenters: Gail D’Onofrio, MD and Andrew Herring, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register […]

  • Ready or Not Here Come the Nitazenes

    Presenter: Edwin Salsitz, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]

  • Women & Alcohol: What does stress have to do with it?

    Join us on Wednesday, November 15th for the #VCBHLectureSeries as we welcome Sherry McKee, PhD, Director, Yale Behavioral Pharmacology Laboratory. Dr. McKee will present "Women & Alcohol: What does stress […]

  • Collaborative Care Model (CoCM) for Substance Use Disorders

    Presenters: Anna Ratzliff, MD, PhD; Jasen Christensen, DO Webinar Description This presentation will review the Collaborative Care Model (CoCM), which is an evidence-based approach to delivering behavioral healthcare in primary […]

  • Overdose-related Compassion Fatigue in Rural Communities

    Erin Winstanley, PhD Visiting Professor, University of Pittsburgh School of Medicine Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, she has postdoctoral training […]

  • Treating Adolescents with Substance Use Disorder

    Presenter: Marc Fishman, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]

  • Northern New England ASAM Annual Conference

    Conference Agenda Day One: 5 PM – 6:30 PM:            Conference Check-in and Welcome Reception Refreshments and social hour. 6:30 PM – 7:30 PM:     […]

    $25 – $150

  • Northern New England ASAM Annual Conference

    Conference Agenda Day Two: 8:30 AM – 8:45 AM:    Welcome Remarks Clifton “Fred” Lord MD, President of NNESAM, ASAM Fellow, Board Certified in Addiction Medicine, CEO/Medical Director/Chairman of the […]

    $25 – $150